The Indian pharmaceutical and healthcare sector saw robust deal activity in Q3, with 72 transactions totaling USD 3.5 billion. This surge, driven by a sharp rebound in private deals and high-value acquisitions like Torrent Pharma's stake in JB Chemicals, reflects renewed investor confidence in the sector's growth potential and consolidation plays.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ZAxQeoK
via IFTTT
No comments:
Post a Comment